The major histocompatibility (MHC) 
Introduction
Several HLA alleles have been reported to be associated to systemic lupus erythematosus (SLE). 1 The mechanism by which these genes determine susceptibility is not completely understood and the participation of unknown susceptibility genes in linkage disequilibrium with those currently detected is being suggested. The gene that codifies for tumor necrosis factor-alpha (TNF-␣) an important inducible proinflamatory cytokine, 2 is located within the major histocompatibility complex (MHC) class III region in human chromosome 6.
3 TNF-␣ polymorphisms have been related in the pathogenesis of SLE, [4] [5] [6] rheumatoid arthritis (RA) 7, 8 and ankylosing spondylitis. Two-biallelic polymorphisms in the promoter region of the TNF-␣ gene have been recently described. The first is located at position −238 in relation to the transcription start site in which the presence of adenine (A) defines the TNFA allele; and the presence of guanine (G) defines the wild-type and more common allele TNFG. 10 The second polymorphism is located at position −308; the presence of G defines the TNF1 allele and A defines TNF2 allele.
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It has been demonstrated that these different allelic forms have functional implications. The TNF2 allelic form results in a two-fold greater transcription greater than the TNF1 form in PMA-stimulated Jurkat and U937 cells. 11 On the other hand, −308 G/A polymorphisms may play a role in the altered TNF-␣ gene expression observed in individuals with the HLA-A1, B8, DR3 haplotype. 12 Association of different susceptibility alleles is particular to different populations. In the Caucasian population, the TNF2 allele has been associated with SLE susceptibility. 13, 14 In South African patients, it has been demonstrated that the TNF2 and HLA-DR alleles contribute independently to susceptibility to SLE while the TNF2 allele did not show any special distribution with particular HLA-DR genotypes. 13 However, in Caucasian patients, the TNF2 allele is in linkage disequilibrium with the HLA-DR3 allele. 15, 16 In the present study we analyzed the allelic and haplotypic distribution of TNF-␣ promoter polymorphisms in Mexican Mestizo SLE patients. Table 1 shows the distribution of TNF-␣ promoter polymorphism genotype and allele frequencies on 51 SLE patients and 55 healthy controls. In both groups, the most common genotypes were TNF −308 1/1 and TNF −238 G/G. The most frequent alleles were TNF1 and TNFG in both groups. The genotype distribution reveals an increase TNF −238 G/A genotype frequency in the SLE patients when compared to healthy controls (Pc = 0.03; OR = 4.77; 95% CI = 1.12-23.23). Also, we observed an increase in the TNFA −238 allele frequency in the patients group (Pc = 0.02; OR = 3.62; 95% CI = 1.17-11.92).
Results
Complete analysis of HLA-DR alleles in patients and healthy controls are shown in Table 2 . In this case, we observed a slight increase of DRB1*0101, *1501, and *1301 alleles frequency in the SLE group, however, none of these alleles remain significant after P-value correction. 
Discussion
In this study we analyzed the TNF-␣ promoter region and DRB1 polymorphisms in SLE Mexican Mestizo patients. Several studies have reported an association of HLA alleles with SLE in different ethnic groups. 13 However, the participation of TNF-␣ polymorphism in the susceptibility to the disease is unclear. In Caucasoid SLE patients, a significant association with TNF2 (gene frequency in SLE group = 0.26 vs gene frequency in controls = 0.16) has been found. 13 These data differ from the TNF2 frequency in South African patients in which the disease is not associated with HLA-DR3. 13 In our study, the frequency of TNF2 allele was not significantly increased in SLE patients when compared to healthy controls with similar ethnic backgrounds. Some studies have suggested a strong linkage disequilibrium between TNF2 and HLA-DR3 in the Caucasian population. Therefore the apparent increase of TNF2 in Caucasian SLE patients may be result of an HLA-DR3 increase. 16 In contrast, other studies did not confirm this data and concludes that the TNF2 and HLA-DR3 are independent susceptibility factors for SLE. 14 The polymorphism on position −308 has been associated with inducible levels of TNF-␣, 11, 12 but this association is not well documented and it contrasts with recently published data, which suggest that this polymorphism does not affect the TNF production. 17 Our preliminary data shows an association between TNFA−238 allele and SLE in the Mexican Mestizo population. However, linkage disequilibrium between TNFA −238 and DRB1*1401, DRB1*0301 alleles were found, suggesting that the association between TNFA −238 and SLE may be a result of this linkage disequilibrium between TNF and DRB alleles in the Mexican SLE patients. In controls, we found a different linkage disequilibrium pattern. These results would suggest that certain TNF-DRB combinations in patients could be important in conferring genetic susceptibility. The lack of association of the HLA-DR alleles in the present study may be a result of the small number of included patients and controls. Previous serological study of HLA alleles in a Mexican population showed an increased frequency of HLA-DR3 allele on SLE patients. 18 A genetic association between TNF −238 G/A heterozygous genotype and RA was recently described in the Caucasian population. However, data provided does not support the evidence of a physiological role of the −238 polymorphism on the TNF-␣ production or gene transcription. 19 On the other hand, recent studies provide further evidence that −308 A and −857 T alleles are associated to RA in patients with 'shared epitope' alleles. 20 Furthermore, there are a number of additional single nucleotide polymorphisms in the promoter region of TNF-␣ at positions −376, −857, −863, and −1031 that could be functional and prove useful for disease association studies.
In conclusion, the TNFA −238 allele frequency is increased in SLE Mexican Mestizo patients. This data suggests that the TNF −238 polymorphism could play an important role in the SLE susceptibility in the Mexican population. The small sample size in the present study could fail to confirm previous associations (−308 and HLA polymorphisms), therefore we considered that additional studies in a large number of patients may help to establish the true significance of these associations in Mexicans.
Materials and methods

Patients
Fifty-one unrelated Mexican Mestizo SLE patients who fulfilled the American College of Rheumatology (ACR) criteria, were studied. As controls 55 healthy Mexican Mestizo individuals, without a case history of connective tissue disorders, were included. We considered those individuals whose last two generations were born in Mexico to be Mexican Mestizo. This group is genetically well characterized and has shown a proportion of 56% Indian genes, 40% Caucasian genes and 4% black genes.
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DNA extraction
Genomic DNA from whole blood containing EDTA was isolated by standard technique.
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TNF
−238 and TNF −308 polymorphisms The TNF polymorphism was evaluated by the previously described amplification refractory mutation system (ARMS) and polymerase chain reaction (PCR). 13 Briefly, the TNF −238 G amplification primers were sense: 5Ј-AGACCCCCCTCGGAATCG-3Ј and antisense: 5Ј-CCGGATCATGCTTTCAGTGC-3Ј (PCR product of 447 bp). The TNF −238 A primers were sense: 5Ј-
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GCCCCTCCCAGTTCTAGTTCTATC-3Ј and antisense: 5Ј-CACACTCCCCATCCTCCCTGGTCT-3Ј (PCR product of 209 bp). As a positive control a 608-bp constant DNA fragment was amplified with primers sense: 5Ј-GCCCCTCCCAGTTCTAGTTCTATC-3Ј and antisense: 5Ј-CCGGATCATGCTTTCAGTGC-3Ј. Hot start PCR condition were followed by five cycles of 94°, 67°and 72°C (60 s each), followed by 25 cycles of 94°, 62°, 72°C (60 s each). The TNF1 −308 polymorphism (characterized by Guanine in −308 position) primers were sense: 5Ј-GGCAATAGGTTTTGAGGGGCGTGG-3Ј and antisense: 5Ј-AAGCGGTAGTGGGCCCTGCACCTT-3Ј (216 bp PCR product), and for the TNF2 −308 allele we used sense: 5Ј-GCCCCTCCCAGTTCTAGTTCTATC-3Ј and antisense 5Ј-ACCCTGGAGGCTGAACCCCGGCCT-3Ј (139 bp PCR product). As internal control a constant PCR band of 354 bp was amplified with sense primer: 5Ј-GCCCCTCCCAGTTCTAGTTCTAT-3Ј and antisense primer: 5Ј-AAGCGGTAGTGGGCCCTGCACCTT-3Ј. Hot start cycling conditions were followed by 30 cycles of 94°, 62°and 72°C (60 s each). The PCR products were analyzed by phototyping in 2% agarose gels, stained with ethidium bromide.
HLA DR typing
Generic HLA-DR typing was performed by PCR-SSO reverse dot blot using the Amplicor Kit (Hoffmann La Roche, Basel, Switzerland). HLA-DRB1 alleles were detected by PCR and hibridization with sequence-specific oligonucleotide probes (SSOP) as previously described. 25 
Statistical analysis
The differences among proportions were evaluated by the Mantel-Haenszel, chi-square test that combined the 2 × 2 contingency tables using the EPIINFO statistical program. If the number in any cell was Ͻ5, Fisher's exact test was used. The P values were corrected by the Bonferroni method multiplying the P value for the number of comparisons. Relative risks (RR) with 95% confidence interval (95% CI) were estimated as the odds ratios. Linkage disequilibrium (D = disequilibrium values; DЈ = normalized disequilibrium values, D/Dmax) between TNF and HLA DR alleles was assessed using the ARLEQUIN statistical program. 26 
